Cefixime / Ornidazole Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200mg + 500mg
Reference Brands: Various Indian Brand Available
Category:
Antibiotics
Cefixime+Ornidazole is used in the treatment of bacterial infections. Cefixime + Ornidazole is a combination of two antibiotics: Cefixime and Ornidazole. Cefixime works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body.
Cefixime / Ornidazole Tablet is available in Tablets
and strengths such as 200mg + 500mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cefixime / Ornidazole Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cefixime / Ornidazole Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cefixime and Ornidazole is a combination antibiotic therapy designed to treat mixed infections caused by bacteria and protozoa. Cefixime, a third-generation cephalosporin, works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Ornidazole, a nitroimidazole derivative, acts by damaging the DNA of anaerobic microorganisms and protozoa, thereby preventing their growth and replication. This dual mechanism makes the combination particularly effective in infections where both aerobic and anaerobic pathogens are involved.
It is commonly prescribed for gastrointestinal infections such as acute diarrhea and dysentery, gynecological infections, urinary tract infections, and other mixed microbial conditions. The combination ensures broader antimicrobial coverage, improving treatment outcomes in cases where single-drug therapy may not be sufficient.
Cefixime and Ornidazole tablets are typically used under medical supervision and should be taken as prescribed by a healthcare professional. Completing the full course of therapy is important to prevent resistance and ensure complete eradication of the infection.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing